Search

Search Constraints

You searched for: Author/Creator Liang, Po‐Cheng

Search Results

1. A real‐world impact of cost‐effectiveness of pegylated interferon/ribavarin regimens on treatment‐naïve chronic hepatitis C patients in Taiwan. Issue 1 (18th November 2016)

2. Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes. Issue 9 (7th June 2022)

3. Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis. Issue 8 (10th March 2021)

4. Cure or curd: Modification of lipid profiles and cardio‐cerebrovascular events after hepatitis C virus eradication. Issue 11 (9th July 2020)

5. Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy. Issue 2 (6th October 2020)

6. Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan—the Formosa‐Like Group. Issue 5 (13th February 2021)

7. Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents. Issue 3 (10th September 2019)

8. Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern Taiwan. Issue 7 (29th April 2022)

9. Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals. Issue 10 (26th September 2017)

10. Real‐world effectiveness of direct‐acting antiviral agents for chronic hepatitis C patients with genotype‐2 infection after completed treatment. Issue 4 (5th November 2020)